LEADER 01365oam  2200445   450 
001 9910707393103321
005 20160707084026.0
035   $a(CKB)5470000002463583
035   $a(OCoLC)953174658
035   $a(OCoLC)995470000002463583
035   $a(EXLCZ)995470000002463583
100   $a20160707d1997      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aQuestionable practices involving nebulizer drug therapy
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d1997.
215   $a1 online resource (iii, 13, A-3 pages)
300   $aTitle from title screen (viewed July 1, 2016).
300   $a"March 1997."
300   $a"OEI-03-94-00391."
606   $aMedicare
606   $aAtomizers
606   $aInhalers
606   $aDrug delivery devices$zUnited States
606   $aRespiratory therapy$zUnited States$xEvaluation
615  0$aMedicare.
615  0$aAtomizers.
615  0$aInhalers.
615  0$aDrug delivery devices
615  0$aRespiratory therapy$xEvaluation.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707393103321
996   $aQuestionable practices involving nebulizer drug therapy$93355777
997   $aUNINA